|
|
|
|
| Intraluminal Gastroplasty Device - Obesity |  | |
|
|
|
|
 | | The Obesity Device is designed to perform incision-less, endoscopic bariatric surgery. Bariatric surgery is generally performed through an external abdominal incision, and sometimes laparoscopically. The traditional surgery has the potential for significant complications, requires an in-patient hospital stay and is expensive. Currently, 350,000 –400,000 bariatric procedures are performed worldwide, each year. |
|
Current Procedures
Require hospital stay
High risk for patients, with high morbidity and mortality
Extended recovery time
Procedures cost $15,000 to $70,000
|
|
Obesity Device
Outpatient procedure
Safer
Faster recovery
Significant cost reduction
|
|
The Obesity Device is introduced through the mouth and esophagus and works by suctioning two sides of the stomach lining into position for suturing, impaling the mucosa or stomach lining, placing a row of sutures through the two sides of the stomach, as commonly done during gastric surgery, injecting adrenaline into the mucosa to elevate it for excision, excising the top layer of the entrapped stomach wall, releasing this tissue, removing the device and tightening the sutures.
We believe that this device will result in significantly less complications and expense, both because of the manner in which the procedure will be performed and the reduced recuperation time.
Patent Pending. Clinical Trials to begin in 2009
|
|
|
|
|
|
|
|